Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse model
暂无分享,去创建一个
Johann de Jong | David J Adams | Touati Benoukraf | Alistair G Rust | Richie Soong | Jean-Pierre Abastado | Lodewyk F A Wessels | A. Rust | G. Radda | D. Adams | L. Wessels | N. Copeland | N. Jenkins | J. Ward | E. Chan | Randy L. Johnson | F. Bard | J. Abastado | T. Benoukraf | R. Soong | A. Dupuy | A. Nguyen | A. Sayadi | L. New | H. Toh | Valerie Chew | Jerrold M Ward | Randy L Johnson | Valerie Chew | Han Chong Toh | Adam J Dupuy | Belinda Q. Chua | Neal G Copeland | Nancy A Jenkins | Emilie A Bard-Chapeau | Anh-Tuan Nguyen | Ahmed Sayadi | Philip Lee | Belinda Q Chua | Lee-Sun New | Christopher K Y Chin | Frederic A Bard | George K Radda | Eric Chun Yong Chan | E. Bard-Chapeau | P. Lee | J. D. Jong
[1] S. Bhatia,et al. An extracellular matrix microarray for probing cellular differentiation , 2005, Nature Methods.
[2] David I. Wilson,et al. A gene trap integration provides an early in situ marker for hepatic specification of the foregut endoderm , 2001, Mechanisms of Development.
[3] Jesse M. Platt,et al. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability , 2011, Proceedings of the National Academy of Sciences.
[4] T. van Groen,et al. Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice. , 2010, The Journal of clinical investigation.
[5] Z. Herceg,et al. Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome. , 2011, Mutation research.
[6] M. Vinciguerra,et al. PTEN at the crossroad of metabolic diseases and cancer in the liver. , 2008, Annals of hepatology.
[7] Hui Cong,et al. Application of 1H NMR‐based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis , 2009, Cancer science.
[8] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[9] D. Botstein,et al. Gene expression patterns in human liver cancers. , 2002, Molecular biology of the cell.
[10] M. Magnuson,et al. DNA excision in liver by an albumin‐Cre transgene occurs progressively with age , 2000, Genesis.
[11] Jiabei Wang,et al. Hippo signaling in oval cells and hepatocarcinogenesis. , 2011, Cancer letters.
[12] Yong Yue,et al. Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis. , 2007, Journal of proteome research.
[13] L. Pannell,et al. Increased RNA‐induced silencing complex (RISC) activity contributes to hepatocellular carcinoma , 2011, Hepatology.
[14] V. Korzh,et al. Camptothecin-induced downregulation of MLL5 contributes to the activation of tumor suppressor p53 , 2011, Oncogene.
[15] Angela M. Liu,et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma , 2012, Nature Genetics.
[16] R. Fisher,et al. Genes Involved in Viral Carcinogenesis and Tumor Initiation in Hepatitis C Virus-Induced Hepatocellular Carcinoma , 2009, Molecular medicine.
[17] Arek Kasprzyk,et al. BioMart: driving a paradigm change in biological data management , 2011, Database J. Biol. Databases Curation.
[18] Ju-Seog Lee,et al. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver , 2010, Proceedings of the National Academy of Sciences.
[19] G. Kristiansen,et al. The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma , 2012, Nature.
[20] T. Scheetz,et al. Novel Molecular and Computational Methods Improve the Accuracy of Insertion Site Analysis in Sleeping Beauty-Induced Tumors , 2011, PloS one.
[21] A. Zhu,et al. The role of signaling pathways in the development and treatment of hepatocellular carcinoma , 2010, Oncogene.
[22] Huanming Yang,et al. Single-Cell Exome Sequencing and Monoclonal Evolution of a JAK2-Negative Myeloproliferative Neoplasm , 2012, Cell.
[23] Ramesh Ramakrishnan,et al. High Throughput Gene Expression Measurement with Real Time PCR in a Microfluidic Dynamic Array , 2008, PloS one.
[24] X. Wang,et al. Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes. , 2013, Gastroenterology.
[25] S. Imbeaud,et al. Tissue metabolomics of hepatocellular carcinoma: Tumor energy metabolism and the role of transcriptomic classification , 2013, Hepatology.
[26] J. Lundeberg,et al. Adenosine kinase deficiency disrupts the methionine cycle and causes hypermethioninemia, encephalopathy, and abnormal liver function. , 2011, American journal of human genetics.
[27] Michael J. Grusby,et al. Zinc Finger Protein Zbtb20 Is Essential for Postnatal Survival and Glucose Homeostasis , 2009, Molecular and Cellular Biology.
[28] D. Kioussis,et al. TEL-AML1 preleukemic activity requires the DNA binding domain of AML1 and the dimerization and corepressor binding domains of TEL , 2007, Oncogene.
[29] B. Edgar,et al. From Cell Structure to Transcription: Hippo Forges a New Path , 2006, Cell.
[30] T. Scheetz,et al. A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice. , 2009, Cancer research.
[31] A. Rust,et al. Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma , 2012, Proceedings of the National Academy of Sciences.
[32] G. Radda,et al. Measuring intracellular pH in the heart using hyperpolarized carbon dioxide and bicarbonate: a 13C and 31P magnetic resonance spectroscopy study , 2009, Cardiovascular research.
[33] R. Deberardinis,et al. Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer , 2010, Oncogene.
[34] B. Fowler,et al. Neonatal hepatic steatosis by disruption of the adenosine kinase gene , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[35] M. Meyerson,et al. Recurrent Hemizygous Deletions in Cancers May Optimize Proliferative Potential , 2012, Science.
[36] Ping Liu,et al. Serum and Urine Metabolite Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma* , 2011, Molecular & Cellular Proteomics.
[37] Marcel J. T. Reinders,et al. Detecting Statistically Significant Common Insertion Sites in Retroviral Insertional Mutagenesis Screens , 2006, PLoS Comput. Biol..
[38] N. Kato,et al. MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma. , 2011, Nature communications.
[39] R. Jackson,et al. Adenosine deaminase and adenosine kinase in rat hepatomas and kidney tumours. , 1978, British Journal of Cancer.
[40] M. V. Heiden,et al. Targeting cancer metabolism: a therapeutic window opens , 2011, Nature Reviews Drug Discovery.
[41] M. Assanah,et al. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer , 2010, Nature.
[42] Martin Ringwald,et al. Mouse Genome Informatics (MGI) Resources for Pathology and Toxicology , 2007, Toxicologic pathology.
[43] J. Ward,et al. Proliferative and Nonproliferative Lesions of the Rat and Mouse Hepatobiliary System , 2010, Toxicologic pathology.
[44] H. Morris,et al. Dihydrouracil dehydrogenase activity in normal, differentiating and regnerating liver and in hepatomas. , 1971, Cancer research.
[45] S. Imbeaud,et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma , 2012, Nature Genetics.
[46] Gerben Duns,et al. Histone methyltransferase gene SETD2 is a novel tumor suppressor gene in clear cell renal cell carcinoma. , 2010, Cancer research.
[47] A. Knudson,et al. A continuum model for tumour suppression , 2011, Nature.
[48] M Holloway,et al. A global view. , 1994, Scientific American.
[49] P. Cohen,et al. The renaissance of GSK3 , 2001, Nature Reviews Molecular Cell Biology.
[50] M. Barton,et al. Zinc finger protein ZBTB20 is a key repressor of alpha-fetoprotein gene transcription in liver , 2008, Proceedings of the National Academy of Sciences.
[51] ENCODEConsortium,et al. An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.
[52] Y. J. Kang,et al. Correction: Corrigendum: MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma , 2012 .
[53] Gregory D. Schuler,et al. Database resources of the National Center for Biotechnology Information: update , 2004, Nucleic acids research.
[54] Hongyue Dai,et al. DLK1-DIO3 Genomic Imprinted MicroRNA Cluster at 14q32.2 Defines a Stemlike Subtype of Hepatocellular Carcinoma Associated with Poor Survival , 2011, The Journal of Biological Chemistry.
[55] V. Mazzaferro,et al. Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma , 2007, Hepatology.
[56] N. Copeland,et al. Harnessing transposons for cancer gene discovery , 2010, Nature Reviews Cancer.
[57] P. Ward,et al. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. , 2012, Cancer cell.
[58] D. Birnbaum,et al. Alterations of NFIA in chronic malignant myeloid diseases , 2009, Leukemia.
[59] A. Rust,et al. Insertional mutagenesis identifies multiple networks of co-operating genes driving intestinal tumorigenesis , 2011, Nature Genetics.
[60] Thomas D. Schmittgen,et al. Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.
[61] W. Bahou,et al. Development of Hepatocellular Carcinoma in Iqgap2-Deficient Mice Is IQGAP1 Dependent , 2008, Molecular and Cellular Biology.
[62] K. Anderson,et al. Genetic variegation of clonal architecture and propagating cells in leukaemia , 2011, Nature.
[63] T. Clemens,et al. Liver-specific Deletion of the Growth Hormone Receptor Reveals Essential Role of Growth Hormone Signaling in Hepatic Lipid Metabolism*♦ , 2009, The Journal of Biological Chemistry.
[64] Lucas Lochovsky,et al. ACT: aggregation and correlation toolbox for analyses of genome tracks , 2011, Bioinform..
[65] A. Ferguson-Smith,et al. Genomic imprinting at the mammalian Dlk1-Dio3 domain. , 2008, Trends in genetics : TIG.
[66] Lewis R. Roberts,et al. Hepatocellular carcinoma: a global view , 2010, Nature Reviews Gastroenterology &Hepatology.
[67] R. Palmiter,et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice , 1989, Cell.
[68] P. Fisher,et al. Multifunction Protein Staphylococcal Nuclease Domain Containing 1 (SND1) Promotes Tumor Angiogenesis in Human Hepatocellular Carcinoma through Novel Pathway That Involves Nuclear Factor κB and miR-221* , 2012, The Journal of Biological Chemistry.
[69] Lia S. Campos,et al. PiggyBac Transposon Mutagenesis: A Tool for Cancer Gene Discovery in Mice , 2010, Science.
[70] Stephanie Roessler,et al. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. , 2010, Cancer research.
[71] R. Deberardinis,et al. Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis , 2007, Proceedings of the National Academy of Sciences.
[72] T. Scheetz,et al. Cell of origin strongly influences genetic selection in a mouse model of T-ALL. , 2011, Blood.
[73] C. Swanton. Intratumor heterogeneity: evolution through space and time. , 2012, Cancer research.
[74] Ru Wei,et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth , 2008, Nature.
[75] Derek Y. Chiang,et al. A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma , 2009, Nature Biotechnology.
[76] S. Imbeaud,et al. Identification of Novel Oncogenes and Tumor Suppressors in Hepatocellular Carcinoma , 2010, Seminars in liver disease.
[77] Data production leads,et al. An integrated encyclopedia of DNA elements in the human genome , 2012 .
[78] T. Mak,et al. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. , 2004, The Journal of clinical investigation.
[79] P. A. Futreal,et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.
[80] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[81] T. Mak,et al. Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.
[82] B. Leggett,et al. Review of genetic and epigenetic alterations in hepatocarcinogenesis , 2006, Journal of gastroenterology and hepatology.
[83] Lanjuan Li,et al. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry. , 2012, Journal of proteome research.
[84] P. Smaglik. A global view , 2005, Nature.
[85] D. Largaespada,et al. Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system , 2005, Nature.
[86] Keith A. Boroevich,et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators , 2012, Nature Genetics.
[87] Zhiming Wang,et al. Downregulation of MAGI1 Associates with Poor Prognosis of Hepatocellular Carcinoma , 2012, Journal of investigative surgery : the official journal of the Academy of Surgical Research.
[88] A. Look,et al. Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP.Ras. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[89] T. Ikegami,et al. Significance of dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expressions in hepatocellular carcinoma , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.
[90] G. Radda,et al. In Vivo hyperpolarized carbon‐13 magnetic resonance spectroscopy reveals increased pyruvate carboxylase flux in an insulin‐resistant mouse model , 2013, Hepatology.